Virginia Regulatory Town Hall View Action

Department of Health Professions

Board of Medicine

Regulations Governing Prescribing of Opioids and Buprenorphine [18 VAC 85 ‑ 21]

Action:

Waiver for e-prescribing of an opioid

General Information

Action Summary	Section 21 is added to Chapter 21 to: 1) reiterate the requirement that takes effect on July 1, 2020 that a prescription for a controlled substance that contains an opioid must be issued as an electronic prescription; and 2) provide for a one-year from the requirement if the practitioner can demonstrate economic hardship technological limitations or other exceptional circumstances beyond the practitioner’s control.
Chapters Affected	Only affects this chapter.
Exempt from APA	No, this action is not exempt from Article II of the APA and executive branch review.
RIS Project	Yes [006085]
Associated Mandates	Waiver for electronic prescribing
New Periodic Review	This action will not be used to conduct a new periodic review.

Stages

Stages associated with this regulatory action.

Stage ID	Stage Type	Status
8714	Emergency/NOIRA	Stage complete. This regulation became effective on 09/18/2019 and expires on 03/17/2021.
8840	Proposed	Stage complete. Comment period ended 11/13/2020.
9156	Final	Governor's office review in progress.

Contact Information

Name / Title:	William L. Harp, M.D. / Executive Director
Address:	9960 Mayland Drive Suite 300 Richmond, VA 23233
Email Address:	william.harp@dhp.virginia.gov
Phone:	(804)367-4558 FAX: (804)527-4429 TDD: ()-

This person is the primary contact for this board.